LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.018333
 41.84 84.90 4190 4003 1.0467 1.0165
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 43.55 84.90 184 4287 0.0429 0.1465
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 43.55 84.90 3333 4287 0.7773 0.9129
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 43.55 84.90 330 4287 0.0770 0.2712
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 43.55 84.90 4526 4287 1.0555 1.0192
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 45.25 84.90 221 4539 0.0487 0.1814
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 45.25 84.90 3650 4539 0.8040 0.9254
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 45.25 84.90 339 4539 0.0747 0.2728
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 45.25 84.90 4870 4539 1.0727 1.0246
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.95 84.90 246 4952 0.0497 0.1988
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.95 84.90 3860 4952 0.7794 0.9168
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.95 84.90 397 4952 0.0802 0.3008
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 46.95 84.90 5250 4952 1.0601 1.0200
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 48.65 84.90 219 5328 0.0411 0.1720
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 48.65 84.90 4184 5328 0.7852 0.9206
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 48.65 84.90 412 5328 0.0773 0.3028
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 48.65 84.90 5607 5328 1.0522 1.0171
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 50.36 84.90 289 5651 0.0511 0.2242
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 50.36 84.90 4391 5651 0.7770 0.9184
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 50.36 84.90 471 5651 0.0833 0.3270
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 50.36 84.90 5868 5651 1.0384 1.0125
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 52.06 84.90 269 5990 0.0449 0.2066
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 52.06 84.90 4666 5990 0.7789 0.9202
MN20160318_Q02
E19
MCF 10A-H2B-mCherry Dasatinib
0.018333
 52.06 84.90 484 5990 0.0808 0.3277
MN20160318_Q02
I17
MCF 10A-H2B-mCherry Dasatinib
0.018333
 52.06 84.90 6250 5990 1.0433 1.0138
MN20160318_Q02
I17